Local authorities on the
Indonesian island of Bali are quietly allowing needle exchange programs
(NEPs) to operate as part of aneffort to reduce the spread of HIV/AIDS
and Hepatitis C among injection drug users in the island nation, the Christian
Science Monitor reported last week. Under Indonesian law, carrying
a syringe without a prescription is a crime, but the threat of needle-borne
disease is causing at least some government officials to look the other
way. Using funds donated from the US and Australia for AIDS prevention,
groups such as Yayasan Hati-Hati (http://ngo.or.id/hatihati/
-- Take Care Foundation in English) in Bali's capital city, Denpasar, are
handing out hundreds of needles each week to drug users, the Monitor reported.
The Denpasar NEP is one of
two currently operating with "government backing, if not explicit legal
approval," according to the Monitor. Six more are set to open around
the archipelago by year's end. NEP workers reported no problems from
police and in one case were provided with identity cards by law enforcement
authorities.
Indonesia, which according
to all reports faces rising heroin use levels -- one study by non-governmental
organizations in 2000 estimated that 25% of Jakarta residents were illegal
drug abusers -- now quietly and unofficially join's Asia's most populous
nations, China and India, in adopting harm reduction measures including
NEPS to fight the transmission of blood-borne diseases.
Nevertheless, repressive
prohibitionism remains popular with both governments and broad sectors
of the population in Asia, as demonstrated by neighboring Thailand's recently
concluded, murderous three-month "war on drugs" and by Indonesia's own
harsh drug laws. Under Law 22/1997, the country's current drug law,
16 people have been sentenced to death for drug trafficking, and six face
imminent execution after having appeals for pardons refused by President
Megawati Sukarnoputri.
-- END --
Issue #287, 5/16/03
Editorial: Coddling Kidnappers | Illinois Over-the-Counter Syringe Bill Passes House, Awaits Governor's Signature | Moves Continue to Win Freedom for Tulia 13 -- Congress to Take a Look | Canada Marijuana Decriminalization Legislation Delayed -- Fears of United States, Discord in Government Cited | Alert and Clarification: Truth in Trials Act | Vote Now in Two Online Marijuana Decriminalization/Legalization Polls | World Social Thematic Forum to Address Drug Policy, Cartagena, Colombia, Next Month | Countdown to Fairness: Celebrity-Led Rockefeller Drug Law Protest Coming June 4th | Six-Year Anniversary of Esequiel Hernandez Shooting This Week | Newsbrief: Indonesia Quietly Supports Needle Exchanges | Newsbrief: US Functionaries Bluster at Bolivia | Newsbrief: US Invasion Liberates Iraqi Heroin, Cocaine Sales | Newsbrief: You Better Watch Yer Ass in Texas, Boy | Newsbrief: Utah Supreme Court Restricts Random Roadblocks, Again | Newsbrief: Supreme Court to Revisit Roadblock Ruling | Newsbrief: This Week's Corrupt Cop Story | Newsbrief: New Jersey Drug Warrior Prescribes More Aggression | The Reformer's Calendar
|
This issue -- main page
This issue -- single-file printer version
Drug War Chronicle -- main page
Chronicle archives
|
PERMISSION to reprint or
redistribute any or all of the contents of Drug War Chronicle (formerly The Week Online with DRCNet is hereby
granted. We ask that any use of these materials include proper credit and,
where appropriate, a link to one or more of our web sites. If your
publication customarily pays for publication, DRCNet requests checks
payable to the organization. If your publication does not pay for
materials, you are free to use the materials gratis. In all cases, we
request notification for our records, including physical copies where
material has appeared in print. Contact: StoptheDrugWar.org: the Drug Reform Coordination Network,
P.O. Box 18402, Washington, DC 20036, (202) 293-8340 (voice), (202)
293-8344 (fax), e-mail drcnet@drcnet.org. Thank
you.
Articles of a purely
educational nature in Drug War Chronicle appear courtesy of the DRCNet
Foundation, unless otherwise noted.